Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma

Future Science OA

Volumn 2, Issue 1, 2016, Pages

  Matlung, Sanne Evelien ^a   Wilhelmina Van Kempen, Pauline Maria ^a   Bovenschen, Niels ^a   Baarle, Debbie Van ^a,b   Willems, Stefan Martin ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

immune cells; immunology; microenvironment; oropharyngeal cancer; prognosis; T cells

Indexed keywords

CANCER PROGNOSIS; CANCER SURVIVAL; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL INFILTRATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MEMORY T LYMPHOCYTE; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; WART VIRUS;

EID: 85032014614     PISSN: None     EISSN: 20565623     Source Type: Journal    
DOI: 10.4155/fso.15.88     Document Type: Review

References (20)

1. Heusinkveld M, Goedemans R, Briet RJP et al. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int. J. Cancer 131(2), E74-E85 (2012).
2. Ritta M, Landolfo V, Mazibrada J et al. Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiol. 36(2), 133-144 (2013).
3. Russell SM, Angell TE, Lechner MG et al. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol. 5(3), 24 (2013).
4. Krupar R, Robold K, Gaag D et al. S Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch. 465(3), 299-312 2014.
5. Lukesova E, Boucek J, Rotnaglova E et al. High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas. Biomed. Res. Int. 2014, 303929 (2014).
6. Hoffmann TK, Arsov C, Schirlau K et al. T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int. J. Cancer 118(8), 1984-1991 (2006).
7. Ward M, Mellows T, Riley C et al. Tumour infiltrating lymphocyt es predict survival in HPV-positive OPSCC. Oral Oncol. 49, S14 (2013).
8. Badoual C, Hans S, Merillon N et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-Associated head and neck cancer. Cancer Res. 73(1), 128-138 (2013).
9. Jung AC, Guihard S, Krugell S et al. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis. Int. J. Cancer 132(2), E26-E36 (2013).
10. Oguejiofor K, Hall J, Slater C et al. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma. Br. J. Cancer 113(6), 886-893 (2015).
11. Partlova S, Boucek J, Kloudova K et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPVassociated compared with non-virally induced head and neck squamous cell carcinoma. Oncoimmunology 4(1), e965570 (2015).
12. Rajjoub S, Basha SR, Einhorn E, Cohen MC, Marvel DM, Sewell DA. Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J. 86(8), 506-511 (2007).
13. Balermpas P, Rodel F, Weiss C, Rodel C, Fokas E. Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer. Oncoimmunology 3(1), e27403 (2014).
14. Al-Taei S, Banner R, Powell N et al. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy. Cancer Immunol. Immunother. 62(12), 1821-1830 (2013).
15. Kong CS, Narasimhan B, Cao H et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 74(2), 553-561 (2009).
16. Nasman A, Romanitan M, Nordfors C et al. Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS ONE 7(6), e38711 (2012).
17. Nordfors C, Grun N, Tertipis N et al. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur. J. Cancer 49(11), 2522-2530 (2013).
18. Turksma A, Bontkes H, van den Heuvel H et al. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients. Oral Dis. 19(6), 577-584 (2013).
19. Wansom D, Light E, Worden F et al. Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch. Otolaryngol. Head Neck Surg. 136(12), 1267-1273 (2010).
20. Wansom D, Light E, Thomas D et al. Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer. Laryngoscope 122(1), 121-127 (2012).